Saturday, October 31, 2026

Ashland And 3 Other Stocks Have Very High Payout Ratio

Ashland And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) - Chesapeake Granite Wash Trust (CHKR), Ashland (ASH), TrustCo Bank Corp NY (TRST) are the highest payout ratio stocks on this list.

We have collected information concerning stocks with the highest payout ratio as yet. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. Chesapeake Granite Wash Trust (CHKR)

100% Payout Ratio

Chesapeake Granite Wash Trust owns royalty interests in oil, natural gas liquids, and natural gas properties located in the Colony Granite Wash play in Washita County in the Anadarko Basin of Western Oklahoma. The company has royalty interests in 69 producing wells and 118 development wells, and in approximately 26,400 net acres of area. As of December 31, 2020, its reserve estimates for the royalty interests included 2,736 thousand barrels of oil equivalent of proved developed reserves. Chesapeake Granite Wash Trust was founded in 2011 and is based in Houston, Texas.

Earnings Per Share

As for profitability, Chesapeake Granite Wash Trust has a trailing twelve months EPS of $0.073.

PE Ratio

Chesapeake Granite Wash Trust has a trailing twelve months price to earnings ratio of 16.44. Meaning, the purchaser of the share is investing $16.44 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 108.07%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Feb 15, 2023, the estimated forward annual dividend rate is 0.29 and the estimated forward annual dividend yield is 22.41%.

2. Ashland (ASH)

38.27% Payout Ratio

Ashland Global Holdings Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. Ashland Global Holdings Inc. offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016. Ashland Global Holdings Inc. was founded in 1924 and is based in Wilmington, Delaware.

Earnings Per Share

As for profitability, Ashland has a trailing twelve months EPS of $3.41.

PE Ratio

Ashland has a trailing twelve months price to earnings ratio of 29.58. Meaning, the purchaser of the share is investing $29.58 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.28%.

Yearly Top and Bottom Value

Ashland's stock is valued at $100.86 at 20:23 EST, way under its 52-week high of $114.36 and way higher than its 52-week low of $86.71.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.5%, now sitting on 2.4B for the twelve trailing months.

Sales Growth

Ashland's sales growth is 5.8% for the current quarter and 6.8% for the next.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Feb 27, 2023, the estimated forward annual dividend rate is 1.34 and the estimated forward annual dividend yield is 1.33%.

3. TrustCo Bank Corp NY (TRST)

35.88% Payout Ratio

TrustCo Bank Corp NY operates as the holding company for Trustco Bank, a federal savings bank that provides personal and business banking services to individuals, partnerships, and corporations. The company accepts deposits; and offers loans and investments. It also operates as a real estate investment trust that acquires, holds, and manages real estate mortgage assets, including residential mortgage loans and mortgage backed securities. In addition, the company serves as the executor of estates and trustee of personal trusts; provides asset and wealth management, estate planning and related advice, and custodial services; and acts as trustee for various types of employee benefit plans, and corporate pension and profit sharing trusts. As of December 31, 2020, it operated 148 banking offices and 164 automatic teller machines in New York, New Jersey, Vermont, Massachusetts, and Florida. The company was founded in 1902 and is headquartered in Glenville, New York.

Earnings Per Share

As for profitability, TrustCo Bank Corp NY has a trailing twelve months EPS of $3.93.

PE Ratio

TrustCo Bank Corp NY has a trailing twelve months price to earnings ratio of 8.64. Meaning, the purchaser of the share is investing $8.64 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.53%.

Moving Average

TrustCo Bank Corp NY's value is below its 50-day moving average of $36.44 and below its 200-day moving average of $34.84.

Sales Growth

TrustCo Bank Corp NY's sales growth is 17.8% for the ongoing quarter and 12.1% for the next.

Yearly Top and Bottom Value

TrustCo Bank Corp NY's stock is valued at $33.97 at 20:23 EST, way below its 52-week high of $39.36 and way higher than its 52-week low of $29.50.

4. Progress Software Corporation (PRGS)

32.56% Payout Ratio

Progress Software Corporation develops, deploys, and manages business applications. The company offers OpenEdge, a development software, which builds multi-language applications for secure deployment across various platforms and devices, as well as cloud; developer tools that consists of components for user interface development for Web, mobile, desktop, chat, and AR/VR apps, as well as automated application testing and reporting tools; Sitefinity, a web content management and customer analytics platform; Corticon, a business rules management system that provides applications with decision automation and change process, and decision-related insight capabilities. It also offers DataDirect Connect, which provides data connectivity using industry-standard interfaces to connect applications running on various platforms; MOVEit that offers secure collaboration and automated file transfers of critical business information; Chef, an infrastructure automation platform to build, deploy, manage, and secure applications in multi-cloud and hybrid environments, and on-premises; and WhatsUp Gold, a network monitoring solution. In addition, the company provides Kemp LoadMaster, a load balancing solutions; and Kemp Flowmon network performance monitoring and diagnostic solutions that collect and analyze network telemetry from various sources. Further, it provides project management, implementation, custom development, programming, and other services, as well as web-enable applications; and training services. The company sells its products to end users, independent software vendors, original equipment manufacturers, and system integrators. It has operations in the United States, Canada, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1981 and is headquartered in Burlington, Massachusetts.

Earnings Per Share

As for profitability, Progress Software Corporation has a trailing twelve months EPS of $2.17.

PE Ratio

Progress Software Corporation has a trailing twelve months price to earnings ratio of 26.53. Meaning, the purchaser of the share is investing $26.53 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.44%.

Sales Growth

Progress Software Corporation's sales growth is 7.6% for the current quarter and 12% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Progress Software Corporation's EBITDA is 54.82.

Moving Average

Progress Software Corporation's value is above its 50-day moving average of $55.55 and way above its 200-day moving average of $49.99.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com